Temporal changes to adult case fatality risk of COVID-19 after vaccination in England between May 2020 and February 2022: a national surveillance study
CONCLUSIONS: COVID-19 CFR reduced after vaccination, with the lowest CFR seen across all age bands when vaccinated up to 6 months prior to specimen date. This provides some evidence for continued booster doses in older age groups.PMID:38096898 | DOI:10.1177/01410768231216332 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 14, 2023 Category: General Medicine Authors: Florence Halford Kathryn Yates Tom Clare Jamie Lopez-Bernal Meaghan Kall Hester Allen Source Type: research
Temporal changes to adult case fatality risk of COVID-19 after vaccination in England between May 2020 and February 2022: a national surveillance study
CONCLUSIONS: COVID-19 CFR reduced after vaccination, with the lowest CFR seen across all age bands when vaccinated up to 6 months prior to specimen date. This provides some evidence for continued booster doses in older age groups.PMID:38096898 | DOI:10.1177/01410768231216332 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 14, 2023 Category: General Medicine Authors: Florence Halford Kathryn Yates Tom Clare Jamie Lopez-Bernal Meaghan Kall Hester Allen Source Type: research
Temporal changes to adult case fatality risk of COVID-19 after vaccination in England between May 2020 and February 2022: a national surveillance study
CONCLUSIONS: COVID-19 CFR reduced after vaccination, with the lowest CFR seen across all age bands when vaccinated up to 6 months prior to specimen date. This provides some evidence for continued booster doses in older age groups.PMID:38096898 | DOI:10.1177/01410768231216332 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 14, 2023 Category: General Medicine Authors: Florence Halford Kathryn Yates Tom Clare Jamie Lopez-Bernal Meaghan Kall Hester Allen Source Type: research
Temporal changes to adult case fatality risk of COVID-19 after vaccination in England between May 2020 and February 2022: a national surveillance study
CONCLUSIONS: COVID-19 CFR reduced after vaccination, with the lowest CFR seen across all age bands when vaccinated up to 6 months prior to specimen date. This provides some evidence for continued booster doses in older age groups.PMID:38096898 | DOI:10.1177/01410768231216332 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 14, 2023 Category: General Medicine Authors: Florence Halford Kathryn Yates Tom Clare Jamie Lopez-Bernal Meaghan Kall Hester Allen Source Type: research
Temporal changes to adult case fatality risk of COVID-19 after vaccination in England between May 2020 and February 2022: a national surveillance study
CONCLUSIONS: COVID-19 CFR reduced after vaccination, with the lowest CFR seen across all age bands when vaccinated up to 6 months prior to specimen date. This provides some evidence for continued booster doses in older age groups.PMID:38096898 | DOI:10.1177/01410768231216332 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 14, 2023 Category: General Medicine Authors: Florence Halford Kathryn Yates Tom Clare Jamie Lopez-Bernal Meaghan Kall Hester Allen Source Type: research
ABO blood group associated with cerebral venous thrombosis after Oxford-AstraZeneca COVID-19 vaccination: a case-control study
CONCLUSIONS: Blood group O is more prevalent among patients with VITT-CVT after ChAdOx1-S vaccination compared with unvaccinated cases, independent of well-established CVT risk factors. A larger dataset may be able to determine whether those of blood groups B and/or AB may be safely vaccinated with the low cost, readily available and easily transported ChAdOx1-S rather than adopting a complete ban.PMID:38086410 | DOI:10.1177/01410768231214341 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 12, 2023 Category: General Medicine Authors: Gie Ken-Dror Pankaj Sharma international Bio-Repository to Establish the Aetiology of Sinovenous Thrombosis (BEAST) collaborators and Cerebral Venous Sinus Thrombosis With Thrombocytopenia Syndrome Study Group Source Type: research
ABO blood group associated with cerebral venous thrombosis after Oxford-AstraZeneca COVID-19 vaccination: a case-control study
CONCLUSIONS: Blood group O is more prevalent among patients with VITT-CVT after ChAdOx1-S vaccination compared with unvaccinated cases, independent of well-established CVT risk factors. A larger dataset may be able to determine whether those of blood groups B and/or AB may be safely vaccinated with the low cost, readily available and easily transported ChAdOx1-S rather than adopting a complete ban.PMID:38086410 | DOI:10.1177/01410768231214341 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 12, 2023 Category: General Medicine Authors: Gie Ken-Dror Pankaj Sharma international Bio-Repository to Establish the Aetiology of Sinovenous Thrombosis (BEAST) collaborators and Cerebral Venous Sinus Thrombosis With Thrombocytopenia Syndrome Study Group Source Type: research
ABO blood group associated with cerebral venous thrombosis after Oxford-AstraZeneca COVID-19 vaccination: a case-control study
CONCLUSIONS: Blood group O is more prevalent among patients with VITT-CVT after ChAdOx1-S vaccination compared with unvaccinated cases, independent of well-established CVT risk factors. A larger dataset may be able to determine whether those of blood groups B and/or AB may be safely vaccinated with the low cost, readily available and easily transported ChAdOx1-S rather than adopting a complete ban.PMID:38086410 | DOI:10.1177/01410768231214341 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 12, 2023 Category: General Medicine Authors: Gie Ken-Dror Pankaj Sharma international Bio-Repository to Establish the Aetiology of Sinovenous Thrombosis (BEAST) collaborators and Cerebral Venous Sinus Thrombosis With Thrombocytopenia Syndrome Study Group Source Type: research
Is the NHS underfunded? Three approaches to answering the question
J R Soc Med. 2023 Dec 7:1410768231214340. doi: 10.1177/01410768231214340. Online ahead of print.NO ABSTRACTPMID:38059823 | DOI:10.1177/01410768231214340 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 7, 2023 Category: General Medicine Authors: Hareth Al-Janabi Iestyn Williams Martin Powell Source Type: research
Is the NHS underfunded? Three approaches to answering the question
J R Soc Med. 2023 Dec 7:1410768231214340. doi: 10.1177/01410768231214340. Online ahead of print.NO ABSTRACTPMID:38059823 | DOI:10.1177/01410768231214340 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 7, 2023 Category: General Medicine Authors: Hareth Al-Janabi Iestyn Williams Martin Powell Source Type: research
Is the NHS underfunded? Three approaches to answering the question
J R Soc Med. 2023 Dec 7:1410768231214340. doi: 10.1177/01410768231214340. Online ahead of print.NO ABSTRACTPMID:38059823 | DOI:10.1177/01410768231214340 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 7, 2023 Category: General Medicine Authors: Hareth Al-Janabi Iestyn Williams Martin Powell Source Type: research
Is the NHS underfunded? Three approaches to answering the question
J R Soc Med. 2023 Dec 7:1410768231214340. doi: 10.1177/01410768231214340. Online ahead of print.NO ABSTRACTPMID:38059823 | DOI:10.1177/01410768231214340 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 7, 2023 Category: General Medicine Authors: Hareth Al-Janabi Iestyn Williams Martin Powell Source Type: research
Is the NHS underfunded? Three approaches to answering the question
J R Soc Med. 2023 Dec 7:1410768231214340. doi: 10.1177/01410768231214340. Online ahead of print.NO ABSTRACTPMID:38059823 | DOI:10.1177/01410768231214340 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 7, 2023 Category: General Medicine Authors: Hareth Al-Janabi Iestyn Williams Martin Powell Source Type: research
Sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists treatment: variable observations of sequelae on diabetic retinopathy
J R Soc Med. 2023 Dec 6:1410768231215999. doi: 10.1177/01410768231215999. Online ahead of print.NO ABSTRACTPMID:38054392 | DOI:10.1177/01410768231215999 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 6, 2023 Category: General Medicine Authors: George I Varughese Sarita Jacob Source Type: research
1948 healthcare: still appropriate today?
J R Soc Med. 2023 Dec 6:1410768231214336. doi: 10.1177/01410768231214336. Online ahead of print.NO ABSTRACTPMID:38054400 | DOI:10.1177/01410768231214336 (Source: J R Soc Med AND (has...)
Source: J R Soc Med AND (has... - December 6, 2023 Category: General Medicine Authors: Mark Zy Tan Source Type: research
